6 Cancer Drugs FDA Approved in August 2026 and What They Mean for You
• The FDA approved six cancer drugs in August 2026, including a new pill for pancreatic cancer called Rasonque. • Patients taking Rasonque lived a median of 13.2 months compared to 6.7 months for those on chemotherapy, reducing the risk of death by roughly 60%. • This approval provides a significant survival increase for pancreatic cancer patients in a disease where gains are typically measured in weeks.
curetoday.com
